4Salmenkivi K, Heikkila P, Haglund C, et al. Malignancy in pheochromocytomas.APMIS,2004,112: 551-559.
5John H, Ziegler WH, Hauri D, et al. Pheochromocytomas:can malignant potential be predicted ? Urology,1999,53:679-683.
6van der Harst E, Bruining HA, Jaap Bonjer H, et al. Proliferative index in pheochromocytomas:does it predict the occurrence of metastases ? J Pathol, 2000,191:175-180.
7Linnoila RI, Keiser HR, Steinberg SM, et al.Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features.Hum Pathol,1990,21:1168-1180.
8van der Harst E, de Herder WW, de Krijger RR, et al.The value of plasma markers for the clinical behaviour of pheochromocytomas. Eur J Endocrinol,2002,147:85-94.
9Plouin PF, Chatellier G, Fofol I, et al.Tumor recurrence and hypertension persistence after successful pheochromocytoma operation.Hypertension,1997,29:1133-1139.
10Klingler HC, Klingler PJ, Martin JK, et al. Pheocromocytoma. Urology,2001,57:1025-1032.
二级参考文献27
1Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol, 2002, 26:551-566.
2Hedley DW, Friedlander ML, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem, 1983, 31:1333-1335.
3Chen YJ, Vortmeyer AO, Zhuang Z, et al. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance. Cancer Res, 2003, 63:817-823.
4Halling KC, Harper J, Moskaluk CA, et al. Origin of microsatellite instability in gastric cancer. Am J Pathol, 1999, 155:205-211.
5Rigaud G, Missiaglia E, Moore PS, et al. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res, 2001, 61:285-292.
6Elder EE, Xu D, Hoog A, et al. Ki-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol, 2003, 16:246-255.
7Bender BU, Gutsche M, Glasker S, et al. Differential genetic alterations in von Hipple-Lindau syndrome-associated and sporadic pheochromocytomas. J Clin Endocrinol Metab, 2000, 85:4568-4574.
8Benn DE, Dwight T, Richardson AL, et al. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Res, 2000, 60:7048-7051.
9Edstrom E, Mahlamaki E, Nord B, et al. Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. Am J Pathol, 2000, 156:651-659.
10Dannenberg H, Speel EJ, Zhao J, et al. Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. Am J Pathol, 2000, 157:353-359.
